+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mosapride"

From
Functional Dyspepsia - Pipeline Insight, 2024 - Product Thumbnail Image

Functional Dyspepsia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Mosapride is a gastroprokinetic drug used to treat gastrointestinal disorders such as gastroesophageal reflux disease (GERD), functional dyspepsia, and irritable bowel syndrome (IBS). It is a selective serotonin 5-HT4 receptor agonist that increases gastrointestinal motility and reduces gastric acid secretion. Mosapride is available in both oral and intravenous formulations and is used in combination with other drugs to treat gastrointestinal disorders. Mosapride is a relatively new drug in the gastrointestinal market and is gaining popularity due to its efficacy and safety profile. It is generally well tolerated and has few side effects. Mosapride is also cost-effective compared to other drugs used to treat gastrointestinal disorders. Some companies in the Mosapride market include Astellas Pharma, Daiichi Sankyo, Takeda Pharmaceuticals, and Shionogi & Co. Ltd. Show Less Read more